MicroRNA 196B regulates FAS-mediated apoptosis in colorectal cancer cells
Metrics: PDF 2236 views | HTML 3035 views | ?
Ji-Su Mo1,*, Khondoker Jahengir Alam1,*, In-Hong Kang1, Won Cheol Park2, Geom-Seog Seo3, Suck-Chei Choi3, Hun-Soo Kim1, Hyung-Bae Moon1, Ki-Jung Yun1,3 and Soo-Cheon Chae1,3
1 Department of Pathology, School of Medicine, Wonkwang University, Iksan, Chonbuk, Republic of Korea
2 Department of Surgery, School of Medicine, Wonkwang University, Iksan, Chonbuk, Republic of Korea
3 Digestive Disease Research Institute, Wonkwang University, Iksan, Chonbuk, Republic of Korea
* These authors contributed equally to this work
Soo-Cheon Chae, email:
Keywords: Fas, MIR196B, Colorectal cancer, Apoptosis
Received: August 11, 2014 Accepted: December 22, 2014 Published: December 26, 2014
Using miRNA microarray analysis, we identified 31 miRNAs that were significantly up-regulated or down-regulated in colon cancer tissues. We chose MIR196B, which was specifically up-regulated in colon cancer, for further study. We identified 18 putative MIR196B target genes by comparing between the mRNAs down-regulated in MIR196B-overexpressed cells and the assumed MIR196B target genes predicted by public bioinformatics tools. The association between MIR196B and FAS was verified in this study. FAS expression was constitutively elevated in normal human colorectal tissues. However, its expression was often reduced in human colorectal cancer. The decrease in FAS expression could be responsible for the reduction of apoptosis in colorectal cancer cells. In colorectal cancer tissue, we showed that MIR196B up-regulation was mutually followed by down regulation of FAS expression. We also showed that MIR196B directly repressed FAS expression in colorectal cells. Furthermore, anti-MIR196B up-regulated FAS expression and increased apoptosis in colorectal cancer cell lines. Our results suggest that the up-regulation of MIR196B modulates apoptosis in colorectal cancer cells by partially repressing FAS expression and that anti-MIR196B could be a potential candidate as an anti-cancer drug in colorectal cancer therapy.
All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.